 SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 GLOBE NEWSWIRE -- Alector, Inc. Nasdaq: ALEC, a clinical-stage biotechnology company pioneering immuno-neurology, today announced the addition of Elizabeth Betsy A. Garofalo, M.D., to the Companys Board of Directors. Dr. Garofalo is a veteran biopharmaceutical executive with more than 25 years of experience in global clinical development and regulatory affairs, with a focus on neurology. 